Antony Fernandes

Dr. Antony Fernandes

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2013 in Science
Verified
Journal Article
Closed access
PDF file
BLBartosz Lewandowski
Bartosz Lewandowski
GBGuillaume De Bo
Guillaume De Bo
JWJohn W. Ward
John W. Ward
MPMarcus Papmeyer
Marcus Papmeyer
SKSonja Kuschel
Sonja Kuschel
DLDavid A. Leigh
David A. Leigh
Ribosomal Rotaxane?: The ribosome is an extraordinarily sophisticated molecular machine, assembling amino acids into proteins based on the precise sequence dictated by messenger RNA. Lewandowski et al. (p. 189 ) have now taken a step toward the preparation of a stripped-down synthetic ribosome analog. Their machine comprises a rotaxane—a ring threaded on a rod—in which the ring bears a pendant thiol that can pluck amino acids off the rod; the terminal nitrogen then wraps around to form a peptide bond and liberate the thiol for further reaction. The system was able to link three amino acids in order from the preassembled rod.

25 February 2015 in Chemical Science
Verified
Journal Article
Open access
PDF file
RBRomain Barat
Romain Barat
TLThibaut Legigan
Thibaut Legigan
ITIsabelle Tranoy-Opalinski
Isabelle Tranoy-Opalinski
BRBrigitte Renoux
Brigitte Renoux
EPElodie Péraudeau
Elodie Péraudeau
SPSébastien Papot
Sébastien Papot
The development of mechanically interlocked molecular systems programmed to operate autonomously in biological environments is an emerging field of research with potential medicinal applications. Within this framework, functional rotaxane- and pseudorotaxane-based architectures are starting to attract interest for the delivery of anticancer drugs, with the ultimate goal to improve the efficiency of cancer chemotherapy. Here, we report an enzyme-sensitive [2]-rotaxane designed to release a potent anticancer drug within tumor cells. The molecular device includes a protective ring that prevents the premature liberation of the drug in plasma. However, once located inside cancer cells the [2]-rotaxane leads to the release of the drug through the controlled disassembly of the mechanically interlocked components, in response to a determined sequence of two distinct enzymatic activations. Furthermore, in vitro biological evaluations reveal that this biocompatible functional system exhibits a noticeable level of selectivity for cancer cells overexpressing β-galactosidase.

12 August 2009 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
AFAntony Fernandes
Antony Fernandes
AVAurélien Viterisi
Aurélien Viterisi
FCFrédéric Coutrot
Frédéric Coutrot
SPStéphanie Potok
Stéphanie Potok
DLDavid A. Leigh
David A. Leigh
SPSébastien Papot
Sébastien Papot

1 November 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NDNihed Draoui
Nihed Draoui
OSOlivier Schicke
Olivier Schicke
AFAntony Fernandes
Antony Fernandes
XDXavier Drozak
Xavier Drozak
Fady NahraFady Nahra
Fady Nahra
OROlivier Riant
Olivier Riant

23 June 2011 in Langmuir
Verified
Journal Article
Closed access
XPXiaowei Pei
Xiaowei Pei
AFAntony Fernandes
Antony Fernandes
BMBertrand Mathy
Bertrand Mathy
XLXavier Laloyaux
Xavier Laloyaux
BNBernard Nysten
Bernard Nysten
AJAlain M. Jonas
Alain M. Jonas

19 July 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
AFAntony Fernandes
Antony Fernandes
OROlivier Riant
Olivier Riant
KJKlavs F. Jensen
Klavs F. Jensen
AJAlain M. Jonas
Alain M. Jonas